As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.
20 Analysts have issued a Wave Life Sciences Ltd. forecast:
20 Analysts have issued a Wave Life Sciences Ltd. forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 109 109 |
104%
104%
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -132 -132 |
11%
11%
|
|
| EBIT (Operating Income) EBIT | -136 -136 |
11%
11%
|
|
| Net Profit | -122 -122 |
14%
14%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
| Head office | Singapore |
| CEO | Paul Bolno |
| Employees | 288 |
| Founded | 2012 |
| Website | www.wavelifesciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


